Limits...
Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality.

Chen Y, Hu S, Wu L, Fang X, Xu W, Shen G - BMJ Open (2015)

Bottom Line: The CPGs performance was less problematic in the domains of 'scope and purpose' and 'clarity and presentation', with a median of 41% for both.After considering the domain scores, 8 CPGs could be recommended with modification for use.Greater efforts should to be devoted to ensure the explicit and transparent reporting of potential conflicts of interest of stakeholders, and to consider the quality of the evidence and grade recommendations in the CPG development process.

View Article: PubMed Central - PubMed

Affiliation: Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, Hefei, Anhui, China.

No MeSH data available.


Related in: MedlinePlus

Flow diagram of guideline selection (CBM, Chinese Biomedical Literature Database; CGC, China Guideline Clearinghouse; CNKI, Chinese National Knowledge Infrastructure).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4513449&req=5

BMJOPEN2015008099F1: Flow diagram of guideline selection (CBM, Chinese Biomedical Literature Database; CGC, China Guideline Clearinghouse; CNKI, Chinese National Knowledge Infrastructure).

Mentions: A total of 7845 articles were identified, 101 of which were considered to be potentially relevant and 17 of which proved eligible for final evaluation, as summarised in figure 1. The general characteristics of the assessed guidelines are shown in table 1.22–38 The publication dates ranged from 2001 to 2011. The number of references cited ranged from 0 to 218, with five guidelines not reporting any references,2631343538 four of which were developed on the Chinese mainland.31343538 The majority of the reviewed CPGs (13 guidelines) were published in Chinese, while four guidelines were published in English,26–2837 two of which were developed in Hong Kong2637 and two in Taiwan.2728 A total of four CPGs23293336 stated that they received drug company sponsorship, but only one of these guidelines declared that the views of the funding bodies did not influence the recommendations, and a declaration of the conflicts of interest of the guideline developers was not provided for 13 CPGs.


Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality.

Chen Y, Hu S, Wu L, Fang X, Xu W, Shen G - BMJ Open (2015)

Flow diagram of guideline selection (CBM, Chinese Biomedical Literature Database; CGC, China Guideline Clearinghouse; CNKI, Chinese National Knowledge Infrastructure).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4513449&req=5

BMJOPEN2015008099F1: Flow diagram of guideline selection (CBM, Chinese Biomedical Literature Database; CGC, China Guideline Clearinghouse; CNKI, Chinese National Knowledge Infrastructure).
Mentions: A total of 7845 articles were identified, 101 of which were considered to be potentially relevant and 17 of which proved eligible for final evaluation, as summarised in figure 1. The general characteristics of the assessed guidelines are shown in table 1.22–38 The publication dates ranged from 2001 to 2011. The number of references cited ranged from 0 to 218, with five guidelines not reporting any references,2631343538 four of which were developed on the Chinese mainland.31343538 The majority of the reviewed CPGs (13 guidelines) were published in Chinese, while four guidelines were published in English,26–2837 two of which were developed in Hong Kong2637 and two in Taiwan.2728 A total of four CPGs23293336 stated that they received drug company sponsorship, but only one of these guidelines declared that the views of the funding bodies did not influence the recommendations, and a declaration of the conflicts of interest of the guideline developers was not provided for 13 CPGs.

Bottom Line: The CPGs performance was less problematic in the domains of 'scope and purpose' and 'clarity and presentation', with a median of 41% for both.After considering the domain scores, 8 CPGs could be recommended with modification for use.Greater efforts should to be devoted to ensure the explicit and transparent reporting of potential conflicts of interest of stakeholders, and to consider the quality of the evidence and grade recommendations in the CPG development process.

View Article: PubMed Central - PubMed

Affiliation: Anhui Evidence-based Medicine Center, Anhui Provincial Hospital, Hefei, Anhui, China.

No MeSH data available.


Related in: MedlinePlus